1 Impact of collagen-induced arthritis on the pharmacokinetic disposition of voriconazole, a widely used antifungal agent: in vitro and in vivo investigations in DBA/1J mice.

2 Invasive Basidiobolomycosis Presenting as Retroperitoneal Fibrosis: A Case Report.

3 hydatid cyst and fungal infection: a case report

4 a case of fatal disseminated apophysomyces elegans infection in a renal allograft recipient

5 outcome of antifungal combination therapy for invasive mold infections in hematological patients is independent of the chosen combination

6 comparison of efficacy of alternative medicine with allopathy in treatment of oral fungal infection

7 ultrasound for critical care physicians: a tempting dilemma

8 mucormycosis isolated from perilymphatic tissue: an unusual presentation

9 candida krusei infection presenting as a right ventricular mass in a two month old infant

10 Perspectives on Scedosporium species and Lomentospora prolificans in lung transplantation: Results of an international practice survey from ESCMID fungal infection study group and study group for infections in compromised hosts, and European Confederation of Medical Mycology

11 Defining breakthrough invasive fungal infection–Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology

12 The role of medical mycology societies in combating invasive fungal infections in low- and middle-income countries: A Nigerian model

13 Successful surgical management of invasive pulmonary fungal infection in patients with leukemia

14 Five-year China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study of invasive fungal infections caused by noncandidal yeasts: species distribution and azole susceptibility

15 New insights into the clinical characteristics and prognostic factors of pulmonary fungal infections from a retrospective study in Southwestern China

16 Liver fungal infections: an overview of the etiology and epidemiology in patients affected or not affected by oncohematologic malignancies

17 Burden and treatment patterns of invasive fungal infections in hospitalized patients in the Middle East: real-world data from Saudi Arabia and Lebanon

18 A critical appraisal of once-daily topical luliconazole for the treatment of superficial fungal infections

19 Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole

20 Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections

21 Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients

22 Update on the optimal use of voriconazole for invasive fungal infections

23 Successful surgical management of invasive pulmonary fungal infection in patients with leukemia

24 Successful surgical management of invasive pulmonary fungal infection in patients with leukemia

25 Five-year China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study of invasive fungal infections caused by noncandidal yeasts: species distribution and azole susceptibility

26 New insights into the clinical characteristics and prognostic factors of pulmonary fungal infections from a retrospective study in Southwestern China

27 Liver fungal infections: an overview of the etiology and epidemiology in patients affected or not affected by oncohematologic malignancies

28 Burden and treatment patterns of invasive fungal infections in hospitalized patients in the Middle East: real-world data from Saudi Arabia and Lebanon

29 A critical appraisal of once-daily topical luliconazole for the treatment of superficial fungal infections

30 Prevention of invasive fungal infections in immunocompromised patients: the role of delayed-release posaconazole

31 Profile of isavuconazole and its potential in the treatment of severe invasive fungal infections

32 Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients

33 Update on the optimal use of voriconazole for invasive fungal infections

34 Empowering women: Moving from awareness to action at the immunology of fungal infections Gordon research conference

35 Interactions between Immune Response to Fungal Infection and MicroRNAs; the Pioneer Tuners.

36 Transplant tourism and invasive fungal infection.

37 Complication of massive trauma by fungal infection and bone tuberculosis

38 The Burden of Serious Fungal Infections in Kyrgyzstan

39 Management of osteoarticular fungal infections in the setting of immunodeficiency.

40 Luminescent-Activated Transfected Killer Cells to Monitor Leukocyte Trafficking During Systemic Bacterial and Fungal Infection

41 Aerobic bacterial and fungal infections in peripheral blood stem cell transplants

42 Recurrent Cellulitis After Coronary Bypass Surgery: Association With Superficial Fungal Infection in Saphenous Venectomy Limbs

43 Fungal infections in neutropenia: current problems and chemotherapeutic control.

44 Fungal infections in neutropenia: current problems and chemotherapeutic control

45 Safety and Efficacy of Activated Transfected Killer Cells for Neutropenic Fungal Infections

46 Invasive fungal infections: biomarkers and molecular approaches to diagnosis

47 Recurrent cellulitis after coronary bypass surgery. Association with superficial fungal infection in saphenous venectomy limbs

48 Aerobic bacterial and fungal infections in peripheral blood stem cell transplants

49 immunotherapy of invasive fungal infection in hematopoietic stem cell transplant recipients

50 virulence of mixed fungal infections in honey bee brood

51 multiple fungal infection in a patient on chronic low dose corticotherapy

52 burden and treatment patterns of invasive fungal infections in hospitalized patients in the middle east: real-world data from saudi arabia and lebanon

53 tratamento pelo fluconazol de pacientes imuno-comprometidos com graves infecções fúngicas treatment by fluconazole of severe fungal infections in immunocompromised patients

54 burden of severe fungal infections in burkina faso

55 clinical safety and tolerability issues in use of triazole derivatives in management of fungal infections

56 the prevalence and pattern of superficial fungal infections among school children in ile-ife, south-western nigeria

57 unusual fungal infections in renal transplant recipients

58 prevalence of fungal infections using national health insurance data from 2009-2013, south korea

59 burden of serious fungal infections in argentina

60 economic evaluation of posaconazole versus standard azole therapy as prophylaxis against invasive fungal infections in patients with prolonged neutropenia in canada

61 the burden of serious fungal infections in cameroon

62 Invasive aspergillosis in patients with hematological malignancies in the Czech and Slovak republics: Fungal InfectioN Database (FIND) analysis, 2005-2009.

63 Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus

64 New spectrum of fungal infections in patients with cancer

65 Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection

66 Strategies to enhance immune function in hematopoietic transplantation recipients who have fungal infections

67 Invasive Bacterial and Fungal Infections Among Hospitalized HIV-Infected and HIV-Uninfected Adults and Adolescents in Northern Tanzania

68 The spectrum of non-Candida fungal infections following bone marrow transplantation

69 Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania

70 Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus

71 Gene Expression Profiling To Predict Viridans Group Streptococcal and Invasive Fungal Infection in Pediatric Acute Myeloid Leukemia: A Brief Report from the Children’s Oncology Group

72 Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)

73 Immunomodulation with interferon-gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia

74 LncRNA6470/ace-miR-750-y axis modulates gene, immune response and survival of eastern honey bee larvae during fungal infection.

Keyword Connections

Journals

Research Groups

Bibliographies